Pfizer launches trial to deliver Covid-19 vaccine to four US states | World News

Pfizer has launched a pilot delivery program for its experimental Covid-19 vaccine in four U.S. states, as the pharmaceutical manufacturer faces distribution challenges posed by its ultra-cold storage requirements.

U.S. The drugmaker said it has selected Rhode Island, Texas, New Mexico and Tennessee for the program because of their size differences, population diversity and immune infrastructure, as well as states need to reach out to different urban and rural people. Settings.

“The four states included in this pilot program will not receive vaccine doses compared to other states based on these pilots, nor will they receive any special consideration,” Pfizer said in a statement.

“We hope that the results of this vaccine distribution pilot will serve as a model for other U.S. states and international governments as they prepare to implement effective Covid-1 vaccine programs.”

A week ago, Pfizer released preliminary data about its vaccine developed with German partner Bioentech SE which showed it was more than 90% effective.

Significantly below the standard for a two-to-eight degree Celsius (36 36–46 ફ F) vaccine, Pfizer’s vaccine must be sent and stored at -70 સે C (-94 ° F).

Earlier on Monday, rival Moderna Inc. said its experimental vaccine was effective in preventing Covid-19 based on data from the end-phase trial, raising hopes that the vaccine against the disease could be ready for use soon. The modern vaccine does not require ultracold freezing, a factor that could prove a major benefit in Pfizer’s production.

Both Pfizer and Moderna vaccines use a new technology called synthetic messenger RNA to activate the immune system against the virus.

Experts have expressed concern about the distribution challenges associated with the Pfizer vaccine due to its special storage requirements.

Given the growing optimism that a vaccine could soon control coronavirus and the economic devastation it causes, the Dow Jones Industrial Average has hit a record high for the first time in nine months.

Leading were stocks of companies that would benefit the most from a developed economy due to forced hibernation, such as airlines, movie theaters and banks.

Epidemic-winning stocks that benefited from lockdown orders like Amazon and Zoom Video Communications were left behind as they no longer seem like the only safe bet to play.

The Dow rose 470.63 points, or 1.6%, to 29,950.44. It surpassed its previous closing record of 29,551.42 set in February before diving stocks plunged into panic.

With Reuters and AP